A GLP-1 medication that's clinically proven to treat weight loss. Clinical trials demonstrated that adults an average of 21% of their starting body weight while using Tirzepatide.
Tirzepatide
The newest GLP-1 medication for weight loss
Taken as a once weekly injection
Patient lose 21% of their starting body weight on average
Always take Tirzepatide as directed by your health care provider. Generally, Tirzepatide is administered as a once weekly subcutaneous injection.
Prescription medications require an online visit with a licensed provider who will determine if the prescription is appropriate.
The most common side effects of Tirzepatide include nausea, constipation, and diarrhea. Rare, but serious side effects include abdominal pain, allergic reactions, dizziness and changes in vision, and rapid heartbeat. Contact your provider immediately if you experience any negative side effects from a medication.
Compounded medications may be prescribed based on personal weight loss needs. While federal law allows the prescription of compounded drugs, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review. Please see additional safety information for more information.
Slows Gastric Emptying
Tirzepatide is a GLP-1 agonist that slows the rate at which your stomach empty food into the small intestine.
Regulates Blood Sugar
Tirzepatide affects the liver and pancreas to limit glucose delivered into the blood stream and increase insulin blood glucose uptake by cells.
Reduces Food Noise
Tirzepatide crosses the blood-brain barrier to limit dopamine released from foods that we often eat too much of.
Compounded Tirzepatide with Renovō costs $549 per month and includes your follow-up visits with your provider and your monthly supply of medication and injection supplies.
No, unlike other providers, Renovō understands that patients experience more progress when they progress through the doses of Tirzepatide as outlined in clinical trials, Therefore, our monthly fee remains the same across all doses.
Insurance does not cover compounded forms of Tirzepatide. However, your care team can submit a prior authorization request to your insurance company for coverage Zepbound®, the commercially available medication. Renovō charges $79 per month for ongoing medication management and follow-up appointments for patients whose insurance covers Zepbound®.
Results and timelines vary from person to person, however most patients begin seeing significant results after four months, which is when the weekly dose of Tirzepatide has reached therapeutical levels.
Weight loss results depend on the individual health history, lifestyle factors, and needs of each patient. Renovō evaluates every patients hormones, currently prescribed medications, and lifestyle to ensure they are receiving whatever support possible in achieving consistent and long-term results.
Yes, both Zepbound® and compounded Tirzepatide are only available if prescribed by a licensed healthcare professional. Your Renovō care team will determine whether this medication is appropriate for you.
Tirzepatide is safe to use for extended periods of time and many patients discontinue use after reaching their weight loss goal. Some patients do regain weight, and therefore can utilize Tirzepatide at lower doses to maintain their progress.
Yes, the compliance processes regulating compounding pharmacies is extremely rigorous. Renovō regularly takes tours of its partner pharmacies and reviews the sterility and quality test results of every batch of compounded medication.
We work only with FDA-inspected, state-regulated compounding pharmacies that exceed regulatory board standards for quality and safety to fulfill our prescriptions for compounded medications.*
Renovō's commitment to quality and safety
Certificate of Analysis (CoA)
Sterility Testing
Potency Testing
pH Testing
Endotoxicity Testing
*Additional quality and safety information can be provided by the pharmacy fulfilling your prescription.